Komori
Share Issuance and Disposal4978ReproCELL IncorporatedMaterials and Chemicals

Notice Concerning Completion of Payment for the Issuance of New Shares and the 17th Stock Acquisition Rights through the 1st Third-Party Allotment under the Share and Stock Acquisition Rights Issuance Program Agreement

Payment by CVI Investments, Inc. for the new shares and Stock Acquisition Rights through the previously approved and disclosed third-party allotment has been completed.

Worth reading
72In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Completion of payment for the issuance of new shares and the 17th Stock Acquisition Rights through a third-party allotment

Who receives how much

New shares 2,932,000 shares / Potential shares underlying the stock acquisition rights 2,932,000 shares (29,320 rights, each convertible into 100 shares)

CVI Investments, Inc.2,932,000 new shares and 29,320 Stock Acquisition Rights

The lower thin line represents the existing number of shares to which these shares will be added.

New shares ¥127 per share / Stock Acquisition Rights ¥133 per right
Total issue value

Stock Acquisition Rights ¥3,899,560

Amount of funds to be raised
New shares ¥372,364,000 / Stock Acquisition Rights ¥502,339,560 (if all rights are exercised at the initial exercise price)
Terms of the stock acquisition rights
Exercise price
¥170 per share. No adjustment to the exercise price. No upper or lower exercise price limits.
Exercise period
Start 12 June 2026 / End 11 June 2030
Number of Stock Acquisition Rights
Total number issued 29,320 rights / Unexercised balance Not disclosed
Payment date
11 June 2026
Most recent equity financing
Resolution dated 27 May 2026 approving the issuance of new shares and Stock Acquisition Rights through a third-party allotment
Details of issuance or disposal
ItemDetails
Type of issuance or disposalCompletion of payment for the issuance of new shares and the 17th Stock Acquisition Rights through a third-party allotment
Number of shares to be issued or disposed ofNew shares 2,932,000 shares / Potential shares underlying the stock acquisition rights 2,932,000 shares (29,320 rights, each convertible into 100 shares)
Issue price and disposal priceNew shares ¥127 per share / Stock Acquisition Rights ¥133 per right
Total issue valueStock Acquisition Rights ¥3,899,560
Amount of funds to be raisedNew shares ¥372,364,000 / Stock Acquisition Rights ¥502,339,560 (if all rights are exercised at the initial exercise price)
Payment date11 June 2026
Intended allotteeName CVI Investments, Inc. / Number of Shares 2,932,000 new shares and 29,320 Stock Acquisition Rights
Exercise price¥170 per share. No adjustment to the exercise price. No upper or lower exercise price limits.
Exercise periodStart 12 June 2026 / End 11 June 2030
Number of Stock Acquisition RightsTotal number issued 29,320 rights / Unexercised balance Not disclosed
Most recent equity financingResolution dated 27 May 2026 approving the issuance of new shares and Stock Acquisition Rights through a third-party allotment
Items this document does not state (17)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The payment procedures for the first third-party allotment approved on 27 May 2026 were completed on 11 June 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Completion of Payment for the Issuance of New Shares and the 17th Stock Acquisition Rights through the 1st Third-Party Allotment under the Share and Stock Acquisition Rights Issuance Program Agreement | ReproCELL Incorporated (4978) timely disclosure | Komori